Dermavant
is a California-based biopharmaceutical company that develops and commercializes therapeutics for patients with immuno-dermatological conditions... Read moreDermavant
is a California-based biopharmaceutical company that develops and commercializes therapeutics for patients with immuno-dermatological conditions... Read more
News
Nov 01, 2024
PMLiVE
Dermavant: Dermavant reports positive long-term results for Vtama cream in atopic dermatitis
Oct 29, 2024
Pharamceutical Technology
Dermavant: Dermavant acquisition expands Organon's dermatology portfolio
Oct 24, 2024
FinanzNachrichten
Dermavant: Dermavant Sciences: Dermavant Presents Data on Achievement of No-to-Minimal Itch and Sleep Improvement in Atopic Dermatitis Patients as Young as Two Years Old at American College of Allergy, Asthma and Immunology Annual Meeting
Sep 20, 2024
Medthority
Dermavant: Organon acquires Dermavant from Roivant and with it Vtama (tapinarof cream) for plaque psoriasis
Sep 20, 2024
Global Legal Chronicle
Dermavant: Organon's Acquisition of Dermavant from Roivant
Aug 30, 2024
MedicalMarketing& Media
Dermavant: Dermavant's storytelling platform turns kids' eczema woes into wins
Jun 25, 2024
FinanzNachrichten
Dermavant: Dermavant Sciences: Dermavant Announces Approval of Tapinarof in both Psoriasis and Atopic Dermatitis in Japan
May 21, 2024
FinanzNachrichten
Dermavant: Dermavant Sciences: Dermavant Announces Publication of ADORING 1 & ADORING 2 Pivotal Phase 3 Trials of VTAMA (tapinarof) cream, 1% for Adults and Children 2 Years of Age and Older with Atopic Dermatitis in JAAD
Apr 29, 2024
FinanzNachrichten
Dermavant: Dermavant Sciences: Dermavant Announces FDA Acceptance of Supplemental New Drug Application (sNDA) for VTAMA (tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older
Mar 14, 2024
PMLiVE
Dermavant: Dermavant reports positive late-stage results for Vtama cream in atopic dermatitis
Dermavant Competitors
1
2
3
4
5
6
7
8
9
10